The Valley Desk

Clinical trial reportAnnals of oncology : official journal of the European Society for Medical OncologyPublished

Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Annals of oncology : official journal of the European Society for Medical Oncology
Published
Subject terms
Humans; Prostate-Specific Antigen; Receptors, Androgen; Ligands; Maximum Tolerated Dose; Aged; Aged, 80 and over; Middle Aged; Male; Androgen Receptor Antagonists; Prostatic Neoplasms, Castration-Resistant; Progression-Free Survival
PubMed ID
39293515
PubMed Central ID
PMC12094577
Added to directory
Source checked

Report a correction or request removal